Source: Clinical Chemistry. Conference titles: AACC Annual Meeting. Unidade: FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2008APA
Hirata, M. H., Marques, M. F. dos S. F., Himelfarb, S. T., Rodrigues, A. C., Silva, F. A., Silva, V. F. da, et al. (2008). Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Hirata MH, Marques MF dos SF, Himelfarb ST, Rodrigues AC, Silva FA, Silva VF da, Monaco MI del, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Hirata RDC. Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-69.[citado 2024 nov. 01 ]Vancouver
Hirata MH, Marques MF dos SF, Himelfarb ST, Rodrigues AC, Silva FA, Silva VF da, Monaco MI del, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Hirata RDC. Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-69.[citado 2024 nov. 01 ]